Clinical Trials in Tennessee

Showing 13261-13280 of 20,239 trials

Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

NCT02614612

To determine if Itacitinib in combination with corticosteroids is safe and tolerable in patients with Grade IIB-IVD acute graft-versus-host disease (GVHD).

Graft-versus-host Disease (GVHD)

Incyte Corporation31 participantsStarted Dec 2015

Duarte, California, United States • La Jolla, California, United States • Los Angeles, California, United States +20 more locations

COMPLETEDNA29 miles

Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

NCT02625181

The purpose of this study is to determine how automated recommendations are best presented to optimize the adherence to guidelines on prophylaxis for nausea and vomiting after surgery.

Postoperative Nausea and Vomiting

Vanderbilt University27,034 participantsStarted Jul 2016

Nashville, Tennessee, United States

Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

Find Trials by Condition in Tennessee

Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

CRT Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients

EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

A Study of LY2484595 on the Electrical Activity of the Heart

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Validation of Non-Invasive Intracranial Pressure (ICP) Monitoring Device

A Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additional 56 Day Course of Itacitinib in Subjects With Active Rheumatoid Arthritis

Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors

A Study of LY2928057 in Hemodialysis Participants

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids

A Study of Ixekizumab in Participants With Plaque Psoriasis

Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation

Inflammation and the Host Response to Injury (Trauma)